| Cvs Pharmacy #01167 | |
| 449 Market St, Elmwood Park, New Jersey 07407 | |
| (201) 794-7975 |
| Name | Cvs Pharmacy #01167 |
|---|---|
| Organization Name | New Jersey Cvs Pharmacy Llc |
| Location | 449 Market St, Elmwood Park, New Jersey 07407 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (201) 794-7975 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Galapagos NV (Euronext: GLPG), Charley's Fund Inc. and the Nash Avery Foundation announced today that they will collaborate to investigate the potential effectiveness of Galapagos' SARM candidate drug, G100192, in treating Duchenne muscular dystrophy. G100192 is an orally-available small molecule therapeutic, which has demonstrated successful Proof of Concept in pre-clinical studies for cachexia (the loss of weight and muscle mass).
Aida Pharmaceuticals, Inc. has announced that it is developing a potential cancer drug that seeks to trigger cell death in certain types of cancer.
Discovery Laboratories, Inc., a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced financial results for the fourth quarter ended December 31, 2013, as well as recent business updates.
"A tight state budget will make an expansion of health care coverage for the poor and disabled unlikely in Ohio this year, an option given to states under President Barack Obama's health care overhaul, the state's Medicaid chief said Thursday. ... it's unclear how many will use Medicaid to fill coverage gaps before 2014, when most of the health care provisions take effect. So far, only Connecticut and the District of Columbia submitted such proposals to the federal government."
Boston Scientific Corporation announces the launch of its BackStop Gel, a new technology designed to prevent stone migration during procedures used to break up and retrieve urinary stones.
› Verified 5 days ago
| NPI Number | 1538251251 |
| Organization Name | NEW JERSEY CVS PHARMACY LLC |
| Doing Business As | CVS PHARMACY 01167 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 449 Market St, Elmwood Park, NJ 07407 |
| Phone Number | 201-794-7975 |
News Archive
Galapagos NV (Euronext: GLPG), Charley's Fund Inc. and the Nash Avery Foundation announced today that they will collaborate to investigate the potential effectiveness of Galapagos' SARM candidate drug, G100192, in treating Duchenne muscular dystrophy. G100192 is an orally-available small molecule therapeutic, which has demonstrated successful Proof of Concept in pre-clinical studies for cachexia (the loss of weight and muscle mass).
Aida Pharmaceuticals, Inc. has announced that it is developing a potential cancer drug that seeks to trigger cell death in certain types of cancer.
Discovery Laboratories, Inc., a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced financial results for the fourth quarter ended December 31, 2013, as well as recent business updates.
"A tight state budget will make an expansion of health care coverage for the poor and disabled unlikely in Ohio this year, an option given to states under President Barack Obama's health care overhaul, the state's Medicaid chief said Thursday. ... it's unclear how many will use Medicaid to fill coverage gaps before 2014, when most of the health care provisions take effect. So far, only Connecticut and the District of Columbia submitted such proposals to the federal government."
Boston Scientific Corporation announces the launch of its BackStop Gel, a new technology designed to prevent stone migration during procedures used to break up and retrieve urinary stones.
› Verified 5 days ago
News Archive
Galapagos NV (Euronext: GLPG), Charley's Fund Inc. and the Nash Avery Foundation announced today that they will collaborate to investigate the potential effectiveness of Galapagos' SARM candidate drug, G100192, in treating Duchenne muscular dystrophy. G100192 is an orally-available small molecule therapeutic, which has demonstrated successful Proof of Concept in pre-clinical studies for cachexia (the loss of weight and muscle mass).
Aida Pharmaceuticals, Inc. has announced that it is developing a potential cancer drug that seeks to trigger cell death in certain types of cancer.
Discovery Laboratories, Inc., a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced financial results for the fourth quarter ended December 31, 2013, as well as recent business updates.
"A tight state budget will make an expansion of health care coverage for the poor and disabled unlikely in Ohio this year, an option given to states under President Barack Obama's health care overhaul, the state's Medicaid chief said Thursday. ... it's unclear how many will use Medicaid to fill coverage gaps before 2014, when most of the health care provisions take effect. So far, only Connecticut and the District of Columbia submitted such proposals to the federal government."
Boston Scientific Corporation announces the launch of its BackStop Gel, a new technology designed to prevent stone migration during procedures used to break up and retrieve urinary stones.
› Verified 5 days ago
Eye Care Optical Type: Medicare Supplier Location: 1 Broadway, Elmwood Park, New Jersey 07407 Phone: (201) 797-5100 | |
Optical Techniques Type: Medicare Supplier Location: 286 Market St, Elmwood Park, New Jersey 07407 Phone: (201) 797-5835 | |
Cvs Pharmacy #01167 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 449 Market St, Elmwood Park, New Jersey 07407 Phone: (201) 794-7975 | |
Walgreen Co 4092 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 593 Market St, Elmwood Park, New Jersey 07407 Phone: (201) 797-5839 | |
Walgreens #6161 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 100 Broadway, Elmwood Park, New Jersey 07407 Phone: (201) 796-0204 |